Articles with public access mandates - Mettine BosLearn more
Not available anywhere: 1
Response: Response to “Clinical relevance of brown snake (Pseudonaja spp) factor V escaping hemostatic regulation”
MHA Bos, M Boltz, L St. Pierre, PP Masci, J De Jersey, MF Lavin, ...
Blood, The Journal of the American Society of Hematology 114 (12), 2563-2564, 2009
Mandates: US National Institutes of Health
Available somewhere: 33
High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor
IM Rietveld, WM Lijfering, S le Cessie, MHA Bos, FR Rosendaal, ...
Journal of Thrombosis and Haemostasis 17 (1), 99-109, 2019
Mandates: Netherlands Organisation for Scientific Research, Dutch Heart Foundation …
The molecular basis of factor V and VIII procofactor activation
RM Camire, MHA Bos
Journal of Thrombosis and Haemostasis 7 (12), 1951-1961, 2009
Mandates: US National Institutes of Health
A bipartite autoinhibitory region within the B-domain suppresses function in factor V
MHA Bos, RM Camire
Journal of Biological Chemistry 287 (31), 26342-26351, 2012
Mandates: US National Institutes of Health
Venom factor V from the common brown snake escapes hemostatic regulation through procoagulant adaptations
MHA Bos, M Boltz, L St. Pierre, PP Masci, J De Jersey, MF Lavin, ...
Blood, The Journal of the American Society of Hematology 114 (3), 686-692, 2009
Mandates: US National Institutes of Health
Lipid levels and risk of venous thrombosis: results from the MEGA-study
VM Morelli, WM Lijfering, MHA Bos, FR Rosendaal, SC Cannegieter
European journal of epidemiology 32, 669-681, 2017
Mandates: Netherlands Organisation for Scientific Research, Dutch Heart Foundation …
Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors
D Verhoef, KM Visscher, CR Vosmeer, KL Cheung, PH Reitsma, ...
Nature communications 8 (1), 528, 2017
Mandates: Netherlands Organisation for Scientific Research
Blood coagulation factors V and VIII: molecular mechanisms of procofactor activation
MHA Bos, RM Camire
Journal of coagulation disorders 2 (2), 19, 2010
Mandates: US National Institutes of Health
Basal but divergent: Clinical implications of differential coagulotoxicity in a clade of Asian vipers
J Debono, MHA Bos, F Coimbra, L Ge, N Frank, HF Kwok, BG Fry
Toxicology in vitro 58, 195-206, 2019
Mandates: Australian Research Council
Coagulotoxic effects by brown snake (Pseudonaja) and taipan (Oxyuranus) venoms, and the efficacy of a new antivenom
CN Zdenek, C Hay, K Arbuckle, TNW Jackson, MHA Bos, B op den Brouw, ...
Toxicology in Vitro 58, 97-109, 2019
Mandates: Australian Research Council
Procoagulant adaptation of a blood coagulation prothrombinase-like enzyme complex in australian elapid venom
MHA Bos, RM Camire
Toxins 2 (6), 1554-1567, 2010
Mandates: US National Institutes of Health
Clinical implications of differential antivenom efficacy in neutralising coagulotoxicity produced by venoms from species within the arboreal viperid snake genus Trimeresurus
J Debono, MHA Bos, N Frank, B Fry
Toxicology Letters 316, 35-48, 2019
Mandates: Australian Research Council
Objectives and design of BLEEDS: a cohort study to identify new risk factors and predictors for major bleeding during treatment with vitamin K antagonists
N van Rein, WM Lijfering, MHA Bos, MH Herruer, HW Vermaas, ...
PloS one 11 (12), e0164485, 2016
Mandates: Dutch Heart Foundation
Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides
MW Bunce, MHA Bos, S Krishnaswamy, RM Camire
Journal of Biological Chemistry 288 (42), 30151-30160, 2013
Mandates: US National Institutes of Health
Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
FA Orsi, JS Biedermann, MJHA Kruip, FJ van der Meer, FR Rosendaal, ...
Journal of Thrombosis and Haemostasis 17 (2), 319-328, 2019
Mandates: Dutch Heart Foundation
Clinical implications of coagulotoxic variations in Mamushi (Viperidae: Gloydius) snake venoms
J Debono, MHA Bos, MS Do, BG Fry
Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology …, 2019
Mandates: Australian Research Council
Major changes of von Willebrand factor multimer distribution in cirrhotic patients with stable disease or acute decompensation
E Palyu, J Harsfalvi, T Tornai, M Papp, M Udvardy, K Szekeres-Csiki, ...
Thrombosis and Haemostasis 118 (08), 1397-1408, 2018
Mandates: National Office for Research, Development and Innovation, Hungary
Factor V levels and risk of venous thrombosis: The MEGA case‐control study
IM Rietveld, MHA Bos, WM Lijfering, R Li‐Gao, FR Rosendaal, ...
Research and Practice in Thrombosis and Haemostasis 2 (2), 320-326, 2018
Mandates: Netherlands Organisation for Scientific Research, Dutch Heart Foundation …
Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation
IM Rietveld, M Schreuder, PH Reitsma, MHA Bos
Thrombosis Research 172, 104-109, 2018
Mandates: Netherlands Organisation for Scientific Research
SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders
MH Cnossen, I van Moort, SH Reitsma, MPM de Maat, REG Schutgens, ...
Journal of Thrombosis and Haemostasis 20 (9), 2001-2011, 2022
Mandates: Netherlands Organisation for Scientific Research
Publication and funding information is determined automatically by a computer program